Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.03 (overall 0.02) | 0.03 |
| cell type Human Protein Atlas | cell type enhanced, including brain excitatory neurons; strongest in neutrophils | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 7667
Sealed predictions
- CELF2 in dopamine neurons, braak+0.43 (p 0.244) → -0.41 (p 0.277)receipt 7673
Swarm cases
receipt 7673: CELF2 in dopamine neurons, braak
- power
- full sample -0.04 (p 0.867, n 18), 95% CI -0.50 to +0.43. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.04 (p 0.867, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.03 (p 0.908, n 18). could be the mix.
- skeptic
- leave-one-out range -0.18 to +0.08, sign flips 5; without severely affected donors -0.04 (p 0.867, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CELF2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts